Trademark: 79337810
Status Date
Wednesday, January 18, 2023
Filing Date
Monday, September 13, 2021
Abandoned Date
Tuesday, January 3, 2023
5 Pharmaceuticals for medical purposes; pharmaceutical and medicinal preparations used in the treatment of non-Hodgkin lymphoma, rheumatoid arthritis, blood cancer, granulomatosis with polyangiitis and microscopic polyangiitis
Feb 14, 2024
Final Decision Transaction Processed By Ib
Jan 22, 2024
Final Disposition Notice Sent To Ib
Jan 18, 2024
Final Disposition Notice Created, To Be Sent To Ib
Oct 3, 2023
Notification Of Possible Opposition - Processed By Ib
Sep 14, 2023
Notification Of Possible Opposition Sent To Ib
Sep 13, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Jan 18, 2023
Abandonment Notice Mailed - Failure To Respond
Jan 18, 2023
Abandonment Notice Mailed - Failure To Respond
Jan 18, 2023
Abandonment - Failure To Respond Or Late Response
Jul 26, 2022
Refusal Processed By Ib
Jul 1, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jul 1, 2022
Refusal Processed By Mpu
Jun 29, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jun 28, 2022
Non-Final Action Written
Jun 16, 2022
Assigned To Examiner
Apr 13, 2022
Application Filing Receipt Mailed
Apr 9, 2022
New Application Office Supplied Data Entered
Apr 7, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
